Vitalhub (TSE:VHI – Get Free Report) was upgraded by analysts at TD Securities to a “strong-buy” rating in a research report issued on Monday,Zacks.com reports.
Separately, Cormark increased their target price on Vitalhub from C$9.50 to C$10.50 and gave the stock a “buy” rating in a report on Wednesday, October 2nd.
View Our Latest Analysis on Vitalhub
Vitalhub Stock Up 0.9 %
Vitalhub Company Profile
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Further Reading
- Five stocks we like better than Vitalhub
- High Flyers: 3 Natural Gas Stocks for March 2022
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- How to Use the MarketBeat Excel Dividend Calculator
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- What is the NASDAQ Stock Exchange?
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.